Literature DB >> 31900365

The effector mechanism of siRNA spherical nucleic acids.

Gokay Yamankurt1,2,3,4, Robert J Stawicki2,3, Diana M Posadas4, Joseph Q Nguyen4, Richard W Carthew5,6, Chad A Mirkin7,3.   

Abstract

Spherical nucleic acids (SNAs) are nanostructures formed by chemically conjugating short linear strands of oligonucleotides to a nanoparticle template. When made with modified small interfering RNA (siRNA) duplexes, SNAs act as single-entity transfection and gene silencing agents and have been used as lead therapeutic constructs in several disease models. However, the manner in which modified siRNA duplex strands that comprise the SNA lead to gene silencing is not understood. Herein, a systematic analysis of siRNA biochemistry involving SNAs shows that Dicer cleaves the modified siRNA duplex from the surface of the nanoparticle, and the liberated siRNA subsequently functions in a way that is dependent on the canonical RNA interference mechanism. By leveraging this understanding, a class of SNAs was chemically designed which increases the siRNA content by an order of magnitude through covalent attachment of each strand of the duplex. As a consequence of increased nucleic acid content, this nanostructure architecture exhibits less cell cytotoxicity than conventional SNAs without a decrease in siRNA activity.

Entities:  

Keywords:  gene regulation; siRNA processing; spherical nucleic acids

Mesh:

Substances:

Year:  2020        PMID: 31900365      PMCID: PMC6983385          DOI: 10.1073/pnas.1915907117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Turkevich method for gold nanoparticle synthesis revisited.

Authors:  J Kimling; M Maier; B Okenve; V Kotaidis; H Ballot; A Plech
Journal:  J Phys Chem B       Date:  2006-08-17       Impact factor: 2.991

2.  Probing the inherent stability of siRNA immobilized on nanoparticle constructs.

Authors:  Stacey N Barnaby; Andrew Lee; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-19       Impact factor: 11.205

3.  RNA interference. Drugging RNAi.

Authors:  Dirk Haussecker; Mark A Kay
Journal:  Science       Date:  2015-03-06       Impact factor: 47.728

4.  Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes.

Authors:  Christian Matranga; Yukihide Tomari; Chanseok Shin; David P Bartel; Phillip D Zamore
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

5.  Molecular requirements for RNA-induced silencing complex assembly in the Drosophila RNA interference pathway.

Authors:  John W Pham; Erik J Sontheimer
Journal:  J Biol Chem       Date:  2005-09-22       Impact factor: 5.157

6.  Selective enhancement of nucleases by polyvalent DNA-functionalized gold nanoparticles.

Authors:  Andrew E Prigodich; Ali H Alhasan; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2011-01-26       Impact factor: 15.419

7.  Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.

Authors:  Kevin Kim; Young Sik Lee; Richard W Carthew
Journal:  RNA       Date:  2006-11-22       Impact factor: 4.942

8.  Gene regulation with polyvalent siRNA-nanoparticle conjugates.

Authors:  David A Giljohann; Dwight S Seferos; Andrew E Prigodich; Pinal C Patel; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

Review 9.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

10.  Cross-Linked Micellar Spherical Nucleic Acids from Thermoresponsive Templates.

Authors:  Resham J Banga; Brian Meckes; Suguna P Narayan; Anthony J Sprangers; SonBinh T Nguyen; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2017-03-20       Impact factor: 15.419

View more
  13 in total

1.  Hairpin-like siRNA-Based Spherical Nucleic Acids.

Authors:  Matthew K Vasher; Gokay Yamankurt; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2022-02-10       Impact factor: 15.419

2.  DNA Dendrons as Agents for Intracellular Delivery.

Authors:  Max E Distler; Michelle H Teplensky; Katherine E Bujold; Caroline D Kusmierz; Michael Evangelopoulos; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2021-08-19       Impact factor: 16.383

3.  Scavenger receptor-targeted plaque delivery of microRNA-coated nanoparticles for alleviating atherosclerosis.

Authors:  Qianqian Bai; Yu Xiao; Huiling Hong; Xiaoyun Cao; Lei Zhang; Ruifang Han; Leo Kit Cheung Lee; Evelyn Y Xue; Xiao Yu Tian; Chung Hang Jonathan Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-19       Impact factor: 12.779

Review 4.  Strategies to deliver RNA by nanoparticles for therapeutic potential.

Authors:  Alysia Cox; Siyoung A Lim; Eun Ji Chung
Journal:  Mol Aspects Med       Date:  2021-08-05

5.  Defining the Design Parameters for in Vivo Enzyme Delivery Through Protein Spherical Nucleic Acids.

Authors:  Caroline D Kusmierz; Katherine E Bujold; Cassandra E Callmann; Chad A Mirkin
Journal:  ACS Cent Sci       Date:  2020-04-27       Impact factor: 14.553

6.  Synthesis of an Azide- and Tetrazine-Functionalized [60]Fullerene and Its Controlled Decoration with Biomolecules.

Authors:  Vijay Gulumkar; Ville Tähtinen; Aliaa Ali; Jani Rahkila; Juan José Valle-Delgado; Antti Äärelä; Monika Österberg; Marjo Yliperttula; Pasi Virta
Journal:  ACS Omega       Date:  2021-12-31

7.  Innovative developments and emerging technologies in RNA therapeutics.

Authors:  François Halloy; Annabelle Biscans; Katherine E Bujold; Alexandre Debacker; Alyssa C Hill; Aurélie Lacroix; Olivia Luige; Roger Strömberg; Linda Sundstrom; Jörg Vogel; Alice Ghidini
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

8.  Spherical nucleic acids: Organized nucleotide aggregates as versatile nanomedicine.

Authors:  Yangmeihui Song; Wenyu Song; Xiaoli Lan; Weibo Cai; Dawei Jiang
Journal:  Aggregate (Hoboken)       Date:  2021-09-14

Review 9.  Gene Regulation Using Spherical Nucleic Acids to Treat Skin Disorders.

Authors:  Thomas R Holmes; Amy S Paller
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-02

10.  NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.

Authors:  Li-Ching Lin; Hsueh-Te Lee; Peng-Ju Chien; Yu-Hao Huang; Mu-Ya Chang; Yueh-Chun Lee; Wen-Wei Chang
Journal:  Int J Med Sci       Date:  2020-08-19       Impact factor: 3.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.